Home>Council Member

Zhang Ligang

Mr. Lee Ligang Zhang has been a successful entrepreneur and business executive since 1998, bringing his knowledge and acumen to a number of companies in his professional career that range from healthcare to the Internet.

Mr. Zhang founded iKang Healthcare Group, Inc. (“iKang”) in December 2004, successfully merging traditional healthcare with a versatile online platform to build a preventative healthcare service network that spanned the entire country. This “anytime, anywhere” network was to become the blueprint for the industry that transformed how customers accessed healthcare services in China.

Since its inception, Mr. Zhang has been serving as its Chairman and Chief Executive Officer, and has overseen many important milestones in its lifetime. iKang was listed on the NASDAQ on April 9, 2014 and is currently the largest provider in China's fast growing private preventive healthcare services market, accounting for approximately 12.3% of market share in terms of revenue in 2013.

Prior to iKang, Mr. Zhang was a co-founder of eLong.com, a NASDAQ-listed online travel service company, and served as CEO of its China operation from 1999 to 2003. From 1998 to 1999, Mr. Zhang served as head of product development at Sohu.com, a leading NASDAQ-listed Chinese Internet company. Mr. Zhang founded the Harvard China Review in 1997 and co-founded the Harvard China Forum in 1998 while studying at Harvard University.

Mr. Zhang studied biology as an undergraduate student at Fudan University in China, and went on to receive a bachelor's degree in biology and chemistry from Concordia College in the US before obtaining a master's degree in genetics from Harvard University. Mr. Zhang has been a member of the Harvard Graduate School of Arts and Science Alumni Association Council since 2005, and also serves as Vice President of the Harvard Club of Beijing and the Shanghai Alumni Association at Fudan University. Mr. Zhang was named as EY Entrepreneur Of The Year 2014 National Life Sciences Award Winner in China in 2014.